SCHEMBL6710133

SCHEMBL6710133

Cc1ccc(-c2cccc3cc(C(=O)Nc4ccc(Br)cc4-c4noc(=O)[nH]4)n(C)c23)s1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.38
HIF1A Q16665 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
ROCK1 Q13464 2/20 0.33
AURKA O14965 1/20 0.33
JAK2 O60674 1/20 0.33
PAK4 O96013 1/20 0.33
NTRK1 P04629 1/20 0.33
FYN P06241 1/20 0.33
CSF1R P07333 1/20 0.33
RET P07949 1/20 0.33
IGF1R P08069 1/20 0.33
PDGFRB P09619 1/20 0.33
PIM1 P11309 1/20 0.33
FGFR1 P11362 1/20 0.33
PRKACA P17612 1/20 0.33
GRK5 P34947 1/20 0.33
KDR P35968 1/20 0.33
MAP2K2 P36507 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6714334 0.91 GRIK1 (0.40) GRIK1RXFP1ROCK1FTO
SCHEMBL6710334 0.88 PDE10A (0.33) GRIK1LMNA
SCHEMBL6709841 0.88 GRIK1 (0.40) GRIK1HIF1ANPSR1RXFP1ROCK1
SCHEMBL6707962 0.87 GRIK1 (0.40) GRIK1HIF1ANPSR1RXFP1ROCK1
SCHEMBL6711606 0.87 GRIK1 (0.42) GRIK1HIF1ANPSR1RXFP1ROCK1
SCHEMBL6710225 0.86 GRIK1 (0.42) GRIK1HIF1ANPSR1RXFP1ROCK1
SCHEMBL6708769 0.85 GRIK1 (0.39) GRIK1HIF1ANPSR1RXFP1ROCK1
SCHEMBL6708988 0.84 KDM4E (0.39) GRIK1NPSR1RXFP1KMT2ALMNA
SCHEMBL6710150 0.84 RXFP1 (0.39) HIF1ANPSR1RXFP1ROCK1AURKA
SCHEMBL6712244 0.83 GRIK1 (0.38) GRIK1HIF1ANPSR1RXFP1ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GRIK1 3885/4885HIF1A 296/4885NPSR1 2999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.